January 27, 2015
Boehringer Ingelheim Pharmaceuticals Inc. on Monday agreed to dismiss its New Jersey federal suit accusing Amneal Pharmaceuticals LLC of patent infringement over its generic version of stroke-prevention drug Aggrenox, saying they have reached a licensing deal.
July 30, 2014
Boehringer Ingelheim Pharmaceuticals Inc. hit Amneal Pharmaceuticals LLC with a lawsuit Wednesday in New Jersey federal court, claiming Amneal's plan to develop a generic version of Aggrenox, a long-acting aspirin, infringes Boehringer's patent on the drug.